Page last updated: 2024-08-23

pirfenidone and Ulcer

pirfenidone has been researched along with Ulcer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Fujiwara, Y; Fukunaga, S; Higashimori, A; Hirano, S; Hosomi, S; Kamata, N; Nadatani, Y; Nagami, Y; Ominami, M; Otani, K; Taira, K; Tanaka, F; Tanigawa, T; Watanabe, T	1

Other Studies

1 other study(ies) available for pirfenidone and Ulcer

Article	Year
Pirfenidone prevents esophageal stricture by inhibiting nucleotide binding oligomerization domain like receptor protein 3 inflammasome activation. Journal of gastroenterology and hepatology, 2022, Volume: 37, Issue:6 Topics: Animals; Carrier Proteins; Caspase 1; Constriction, Pathologic; Esophageal Stenosis; Fibrosis; Humans; Inflammasomes; Interleukin-1beta; NLR Family, Pyrin Domain-Containing 3 Protein; Nucleotides; Pyridones; Rats; Ulcer	2022

Article

Year

Pirfenidone prevents esophageal stricture by inhibiting nucleotide binding oligomerization domain like receptor protein 3 inflammasome activation.

Journal of gastroenterology and hepatology, 2022, Volume: 37, Issue:6

Topics: Animals; Carrier Proteins; Caspase 1; Constriction, Pathologic; Esophageal Stenosis; Fibrosis; Humans; Inflammasomes; Interleukin-1beta; NLR Family, Pyrin Domain-Containing 3 Protein; Nucleotides; Pyridones; Rats; Ulcer

2022